The Effect of Bright Light Treatment on Rest-Activity Rhythms in People with Dementia: A 24-Week Cluster Randomized Controlled Trial

被引:5
|
作者
Kolberg, Eirin [1 ]
Pallesen, Stale [2 ,3 ,4 ]
Hjetland, Gunnhild Johnsen [1 ,5 ]
Nordhus, Inger Hilde [1 ,6 ]
Flo-Groeneboom, Elisabeth [1 ]
机构
[1] Univ Bergen UiB, Fac Psychol, Dept Clin Psychol, N-5009 Bergen, Norway
[2] Univ Bergen UiB, Fac Psychol, Dept Psychosocial Sci, N-5015 Bergen, Norway
[3] Haukeland Hosp, Norwegian Competence Ctr Sleep Disorders, N-5021 Bergen, Norway
[4] North West Univ, Optentia, Vaal Triangle Campus, ZA-1911 Vanderbijlpark, South Africa
[5] City Dept Hlth & Care, N-5007 Bergen, Norway
[6] Univ Oslo UiO, Fac Med, Dept Behav Med, N-0372 Oslo, Norway
来源
CLOCKS & SLEEP | 2021年 / 3卷 / 03期
关键词
dementia; nursing homes; bright light therapy; rest-activity rhythms; actigraphy; circadian rhythms; clinical trial; CIRCADIAN ACTIVITY RHYTHMS; NURSING-HOME RESIDENTS; MINI-MENTAL-STATE; ALZHEIMERS-DISEASE; INSTITUTIONALIZED PATIENTS; MELATONIN SECRETION; SLEEP; EXPOSURE; DISTURBANCES; INTERVENTION;
D O I
10.3390/clockssleep3030032
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Bright light treatment is an effective way to influence circadian rhythms in healthy adults, but previous research with dementia patients has yielded mixed results. The present study presents a primary outcome of the DEM.LIGHT trial, a 24-week randomized controlled trial conducted at nursing homes in Bergen, Norway, investigating the effects of a bright light intervention. The intervention consisted of ceiling-mounted LED panels providing varying illuminance and correlated color temperature throughout the day, with a peak of 1000 lx, 6000 K between 10 a.m. and 3 p.m. Activity was recorded using actigraphs at baseline and after 8, 16, and 24 weeks. Non-parametric indicators and extended cosine models were used to investigate rest-activity rhythms, and outcomes were analyzed with multi-level regression models. Sixty-one patients with severe dementia (median MMSE = 4) were included. After 16 weeks, the acrophase was advanced from baseline in the intervention group compared to the control group (B = -1.02, 95%; CI = -2.00, -0.05). There was no significant difference between the groups on any other rest-activity measures. When comparing parametric and non-parametric indicators of rest-activity rhythms, 25 out of 35 comparisons were significantly correlated. The present results indicate that ambient bright light treatment did not improve rest-activity rhythms for people with dementia.
引用
收藏
页码:449 / 464
页数:16
相关论文
共 50 条
  • [11] The effect of a social robot intervention on sleep and motor activity of people living with dementia and chronic pain: A pilot randomized controlled trial
    Pu, Lihui
    Moyle, Wendy
    Jones, Cindy
    Todorovic, Michael
    MATURITAS, 2021, 144 : 16 - 22
  • [12] Ambient bright light treatment improved proxy-rated sleep but not sleep measured by actigraphy in nursing home patients with dementia: a placebo-controlled randomised trial
    Hjetland, Gunnhild J.
    Kolberg, Eirin
    Pallesen, Stale
    Thun, Eirunn
    Nordhus, Inger Hilde
    Bjorvatn, Bjorn
    Flo-Groeneboom, Elisabeth
    BMC GERIATRICS, 2021, 21 (01)
  • [13] A 24-Week, Randomized, Controlled Trial of Rivastigmine Patch 13.3 mg/24 h Versus 4.6 mg/24 h in Severe Alzheimer's Dementia
    Farlow, Martin R.
    Grossberg, George T.
    Sadowsky, Carl H.
    Meng, Xiangyi
    Somogyi, Monique
    CNS NEUROSCIENCE & THERAPEUTICS, 2013, 19 (10) : 745 - 752
  • [14] Multisensory stimulation for elderly with dementia: A 24-week single-blind randomized controlled pilot study
    Milev, Roumen V.
    Kellar, Tracey
    McLean, Marilyn
    Mileva, Vick
    Luthra, Veb
    Thompson, Shiela
    Peever, Linda
    AMERICAN JOURNAL OF ALZHEIMERS DISEASE AND OTHER DEMENTIAS, 2008, 23 (04): : 372 - 376
  • [15] Efficacy and tolerability of donepezil in vascular dementia -: Positive results of a 24-week, multicenter, international, randomized, placebo-controlled clinical trial
    Black, S
    Román, GC
    Geldmacher, DS
    Salloway, S
    Hecker, J
    Burns, A
    Perdomo, C
    Kumar, D
    Pratt, R
    STROKE, 2003, 34 (10) : 2323 - 2330
  • [16] Circadian rest-activity rhythms during benzodiazepine tapering covered by melatonin versus placebo add-on: data derived from a randomized clinical trial
    Baandrup, Lone
    Fasmer, Ole Bernt
    Glenthoj, Birte Yding
    Jennum, Poul Jorgen
    BMC PSYCHIATRY, 2016, 16
  • [17] Effects on sleep from group activity with a robotic seal for nursing home residents with dementia: a cluster randomized controlled trial
    Joranson, Nina
    Olsen, Christine
    Calogiuri, Giovanna
    Ihlebaek, Camilla
    Pedersen, Ingeborg
    INTERNATIONAL PSYCHOGERIATRICS, 2021, 33 (10) : 1045 - 1056
  • [18] Neuropsychiatric symptoms in dementia and the effects of Ginkgo biloba extract EGb 761 (R) treatment: additional results from a 24-week randomized, placebo-controlled trial
    Nacu, Anatol
    Hoerr, Robert
    OPEN ACCESS JOURNAL OF CLINICAL TRIALS, 2016, 8 : 1 - 6
  • [19] Change in quality of life after a multidisciplinary intervention for people with dementia: A cluster randomized controlled trial
    Klapwijk, Maartje S.
    Caljouw, Monique A. A.
    Pieper, Marjoleine J. C.
    Putter, Hein
    van der Steen, Jenny T.
    Achterberg, Wilco P.
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2018, 33 (09) : 1213 - 1219
  • [20] Effects of galantamine and galantamine combined with nimodipine on cognitive speed and quality of life in mixed dementia: a 24-week, randomized, placebo-controlled exploratory trial (the REMIX study)
    Caramelli, Paulo
    Laks, Jerson
    Fernandes Palmini, Andre Luis
    Nitrini, Ricardo
    Fagundes Chaves, Marcia Lorena
    Forlenza, Orestes Vicente
    Carvalho do Vale, Francisco de Assis
    Barbosa, Maira Tonidandel
    de Campos Bottino, Cassio Machado
    Machado, Joao Carlos
    Charchat-Fichman, Helenice
    Lawson, Fabio Lorea
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2014, 72 (06) : 411 - 417